# MiMedx Group (MDXG) — News

MDXG · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/mdxg/news

## Recent headlines

- [Med-X: Registers resale of up to 13,052,103 shares for direct listing on Nasdaq by registered stockholders - SEC filing](https://www.ainvest.com/news/med-registers-resale-13-052-103-shares-direct-listing-nasdaq-registered-stockholders-sec-filing-2609) — AInvest Wire, Sep 28, 2026
  MiMedx Group, Inc. (NASDAQ: MDXG) has filed with the U.S. Securities and Exchange Commission (SEC) to register the resale of up to 13,052,103 shares of its common stock by registered stockholders under a direct listing on Nasdaq. The filing, which is part of the company’s broader strategic…
- [Mimedx Group: Court vacates FDA determinations that Axifill is not minimally manipulated and should be classified as a biological product](https://www.ainvest.com/news/mimedx-group-court-vacates-fda-determinations-axifill-minimally-manipulated-classified-biological-product-2609) — AInvest Wire, Sep 23, 2026
  A federal court in Georgia has ruled that the Food and Drug Administration (FDA) must reassess its classification of Mimedx Group’s wound care product Axifill as a biological product. The court vacated the FDA’s determination that Axifill is not minimally manipulated, which had subjected the…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).